Scientists writing in the journal Nature Medicine say increasing intake of the omega-3 fatty acids DHA and EPA, found in popular fish-oil supplements, may protect against blindness resulting from abnormal blood vessel growth in the eye.

The study was done in mice, but a clinical trial at Children’s Hospital Boston will soon begin testing the effects of omega-3 supplementation in premature babies, who are at risk for vision loss.

advertisement

Retinopathy, affecting about 4 million diabetic patients and about 40,000 premature infants in the United States, is a two-step disease that begins with a loss of blood vessels in the retina (the nerve tissue at the back of the eye that sends visual signals to the brain).

Because of the vessel loss, the retina becomes oxygen-starved and sends out alarm signals that spur new vessel growth. But the new vessels grow abnormally and are malformed, leaky and over-abundant.

In the end stage of the disease, the abnormal vessels pull the retina away from its supporting layer, and this retinal detachment ultimately causes blindness.

The researchers, led by Dr. Lois Smith, and Kip Connor, PhD, of Children’s Hospital Boston’s Department of Ophthalmology and Harvard Medical School, and John Paul SanGiovanni, ScD, of the National Eye Institute (NEI) at the National Institutes of Health, studied retinopathy in a mouse model, feeding the mice diets that emphasized either omega-3 fatty acids (comparable to a Japanese diet) or omega-6 fatty acids (comparable to a Western diet).

Mice on the omega-3 diet, rich in DHA (docosahexaenoic acid) and its precursor EPA (eicosapentaenoic acid), had less initial vessel loss in the retina than the omega-6-fed mice: the area with vessel loss was 40% to 50% smaller. As a result, the omega-3 group had a 40% to 50% decrease in pathological vessel growth.

"Our studies suggest that after initial loss, vessels re-grew more quickly and efficiently in the omega-3-fed mice," says Connor, the study’s first author.

"This increased the oxygen supply to retinal tissue, resulting in a dampening of the inflammatory ‘alarm’ signals that lead to pathologic vessel growth."

Because omega-3 fatty acids are highly concentrated in the retina, a mere 2% change in dietary omega-3 intake was sufficient to decrease disease severity by 50%, the researchers note.

Validating their findings, results were virtually identical in mice whose omega-3 fatty acid levels were increased through genetic means.

Omega-3 fatty acids like DHA and EPA are thought to dampen inflammation in the body. They are often lacking in Western diets; instead, omega-6 fatty acids predominate. The ideal omega-6-to-omega-3 ratio is thought to be 2:1 to 5:1, whereas typical Western diets have ratios of 10:1 or higher.

Premature infants are especially lacking in omega-3 fatty acids, because they miss getting this nutrient from their mothers, a transfer that normally happens in the third trimester of pregnancy.

The researchers demonstrated that the omega-3-based diet suppressed production of TNF-alpha, reducing the inflammatory response in the retina, whereas the omega-6-based diet increased TNF-alpha production. The retinas of omega-3-fed mice also had increased production of the anti-inflammatory compounds neuroprotectinD1, resolvinD1 and resolvinE1.

These compounds, derived from omega-3 fatty acids, also potently protected against pathological vessel growth, and they were not detected in the retinas of mice fed the omega-6 diet.

"If omega-3 fatty acids, or these anti-inflammatory mediators, are as effective in humans and they are in mice, simple supplementation could be a cost-effective intervention benefiting millions of people," says Smith, the study’s senior investigator. "The cost of blindness is enormous."

Aside from fish-oil supplements, the most widely available source of omega-3 fatty acids is coldwater oily fish (wild salmon, herry, mackerel, anchovies, sardines). The compounds can also be made synthetically from algae or other non-fish sources.

(Article courtesy of ConsumerAffairs.com)